COMMUNIQUÉS West-GlobeNewswire

CareDx Further Simplifies its Balance Sheet

15/11/2017 - 15:00

BRISBANE, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Progressive Care Reports Stellar Third Quarter Results

15/11/2017 - 14:30

MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City

15/11/2017 - 14:30

TUCSON, Ariz., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference in New [...]

Skyline Medical and Helomics Corporation Sign Joint Venture Term Sheet to Build-out and Commercialize the D-CHIP™ platform

15/11/2017 - 14:30

MINNEAPOLIS, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017

15/11/2017 - 14:30

PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017. The net loss was $1.3 million for the three [...]

Progressive Care Reports Stellar Third Quarter Results

15/11/2017 - 14:30

MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

Onconova Therapeutics Announces Publication of Results from Phase 1/2 Study of Rigosertib in Patients with Myelodysplastic Syndromes (MDS) and MDS Progressed to Acute Myeloid Leukemia

15/11/2017 - 14:30

Rigosertib reduced or stabilized bone marrow blasts and improved peripheral blood counts Patients with response or stable disease had one year longer survival than non-responders Rigosertib was well tolerated and a [...]

Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights

15/11/2017 - 14:25

Investor Conference Call to be held Monday, November 20th at 10:00 am ET Global enrollment continues in ABO-102 trial for MPS IIIA Screening initiated in ABO-101 Phase 1/2 trial for MPS IIIB Pivotal Phase 3 planning [...]

ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions

15/11/2017 - 14:08

RAMSEY, N.J. and BOCA RATON, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) is a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and [...]

Medovex Corporation Initiates Move to List on the OTCQB Market

15/11/2017 - 14:00

ATLANTA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (NASDAQ: MDVX ) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]

Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance

15/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director

15/11/2017 - 14:00

ORLANDO, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical [...]

Cytori Reminds Stockholders That Rights Offering Expires on Tuesday, November 21

15/11/2017 - 14:00

SAN DIEGO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) provides a reminder to stockholders that its previously announced rights offering will remain open until 5:00 PM Eastern Time on [...]

Enrolment of First Cohort Completed with Eighth Participant Dosed in Cynata’s World First Clinical Trial

15/11/2017 - 14:00

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), is pleased to provide an update on the progress of the clinical [...]

BioSyent Releases Results for Third Quarter and First Nine Months of 2017

15/11/2017 - 14:00

TORONTO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three and nine months ended September 30, 2017. Key highlights include: [...]

Biotricity FDA Submission Update

15/11/2017 - 14:00

REDWOOD CITY, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

Enzymotec Ltd. Reports Third Quarter 2017 Unaudited Financial Results

15/11/2017 - 13:35

MIGDAL HA’EMEQ, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq: ENZY ), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products, today reported [...]

Matinas BioPharma Reports 2017 Third Quarter Financial Results and Provides Corporate Update

15/11/2017 - 13:35

BEDMINSTER, N.J., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, [...]

Foamix Reports Third Quarter 2017 Financial Results and Provides Business Update

15/11/2017 - 13:00

Conference Call and Webcast on Wednesday, November 15, 2017 at 8:30am Eastern / 5:30am Pacific REHOVOT, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix Pharmaceuticals” or [...]